These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4954605)

  • 21. ERYTHROCYTE CHIMERISM AND ACQUIRED IMMUNOLOGIC TOLERANCE.
    WILSON WE; TALMAGE DW
    J Immunol; 1965 Jan; 94():150-6. PubMed ID: 14253513
    [No Abstract]   [Full Text] [Related]  

  • 22. Bone-marrow transplantation (second of two parts).
    Thomas ED; Storb R; Clift RA; Fefer A; Johnson L; Neiman PE; Lerner KG; Glucksberg H; Buckner CD
    N Engl J Med; 1975 Apr; 292(17):895-902. PubMed ID: 235092
    [No Abstract]   [Full Text] [Related]  

  • 23. Presence of specific suppressor cells as a result of induction of neonatal transplantation tolerance.
    Holán V; Chutná J; Hasek M
    Folia Biol (Praha); 1978; 24(6):409. PubMed ID: 365616
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing.
    Wood ML; Monaco AP; Gozzo JJ; Liegeois A
    Transplant Proc; 1971 Mar; 3(1):676-9. PubMed ID: 4398508
    [No Abstract]   [Full Text] [Related]  

  • 25. Cell-mediated immunity and blocking serum activity before and after breakage of allograft tolerance in rats.
    Bansal SC; Hellström I; Hellström KE; Wright PW
    Transplantation; 1973 Dec; 16(6):610-20. PubMed ID: 4585385
    [No Abstract]   [Full Text] [Related]  

  • 26. [Organ tolerance and incomplete bone marrow chimera in dogs].
    von Scheel J; Kolb HJ; Chaussy C; Rieder I; Duswald KH; Pielsticker K
    Chir Forum Exp Klin Forsch; 1977 Apr; ():274-8. PubMed ID: 376244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial tolerance and immunity after adoptive abrogation of transplantation tolerance in the rat.
    Elkins WL; Adams JS; Fox DH; Wilson DB; Stuart FP
    Cell Immunol; 1973 Dec; 9(3):412-25. PubMed ID: 4148477
    [No Abstract]   [Full Text] [Related]  

  • 28. [INFLUENCE OF THE THYMUS AND THE ORIGIN OF RESTORATIVE CELLS ON THE IMMUNOLOGIC FUNCTIONS OF ISOGENIC RADIOCHIMERAS].
    DUPLAN JF
    Ann Inst Pasteur (Paris); 1965 Jan; 108():1-12. PubMed ID: 14289979
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunologic problems in allogenic and autologous bone marrow transplantation].
    Schwenke H; Helbig W; Kubel M; Schultze W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(2):217-23. PubMed ID: 6208106
    [No Abstract]   [Full Text] [Related]  

  • 30. Mixed chimerism as an approach for the induction of transplantation tolerance.
    Wekerle T; Sykes M
    Transplantation; 1999 Aug; 68(4):459-67. PubMed ID: 10480398
    [No Abstract]   [Full Text] [Related]  

  • 31. SUCCESSFUL ALLOGENIC BONE MARROW TRANSPLANTATION IN MAN: CHIMERISM, INDUCED SPECIFIC TOLERANCE AND POSSIBLE ANTI-LEUKEMIC EFFECTS.
    MATHE G; AMIEL JL; SCHWARZENBERG L; CATTAN A; SCHNEIDER M; DEVRIES MJ; TUBIANA M; LALANNE C; BINET JL; PAPIERNIK M; SEMAN G; MATSUKURA M; MERY AM; SCHWARZMANN V; FLAISLER A
    Blood; 1965 Feb; 25():179-96. PubMed ID: 14267694
    [No Abstract]   [Full Text] [Related]  

  • 32. Parameters of allogeneic unresponsiveness in canine radiation chimerae, with particular reference to the possible existence of three closely linked genetic systems relevant to bone marrow transplantation.
    Rapaport FT; Ozaki A; Cannon FD; Mollen M; Blumenstock D; Ayvazian JH; Ferrebee JW
    Transplant Proc; 1973 Mar; 5(1):845-52. PubMed ID: 4572147
    [No Abstract]   [Full Text] [Related]  

  • 33. [Obstacles in the immunotherapy of cancer].
    Ishibashi U
    Geka Chiryo; 1967 Nov; 17(5):515-21. PubMed ID: 4877442
    [No Abstract]   [Full Text] [Related]  

  • 34. KIDNEY HOMOGRAFTS: INDUCTION OF SPECIFIC TOLERANCE THROUGH THE LYMPHOID TISSUES.
    PARRA J; TORRES JA; ALVAREZ F; VELA R; ALBERT C; OLIVA H
    Ann N Y Acad Sci; 1964 Nov; 120():524-34. PubMed ID: 14235270
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunological enhancement, blocking factors, and tolerance to tumours, transplants and foetuses.
    Halliday WJ
    Aust N Z J Med; 1972 Nov; 2(4):416-21. PubMed ID: 4572903
    [No Abstract]   [Full Text] [Related]  

  • 36. [Disease secondary to the allogenic bone marrow graft in man. Histo-pathologic aspects].
    Chomette G; Mathé G; de Vries MJ; Van Bekkum DW
    Arch Anat Pathol (Paris); 1970 Jun; 18(2):107-14. PubMed ID: 4393331
    [No Abstract]   [Full Text] [Related]  

  • 37. New approaches to transplantation tolerance.
    Smith CV; Rosengard BR; Guzzetta PC; Nakajima K; Sachs DH
    Transplant Proc; 1991 Aug; 23(4):2157-61. PubMed ID: 1871834
    [No Abstract]   [Full Text] [Related]  

  • 38. The cellular basis of transplantation tolerance.
    Elkins WL
    Transplant Proc; 1973 Mar; 5(1):685-9. PubMed ID: 4144461
    [No Abstract]   [Full Text] [Related]  

  • 39. "Spare parts" revisited.
    Rapaport FT
    Transplant Proc; 1975 Sep; 7(3):343-50. PubMed ID: 1099740
    [No Abstract]   [Full Text] [Related]  

  • 40. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment.
    Wekerle T; Kurtz J; Ito H; Ronquillo JV; Dong V; Zhao G; Shaffer J; Sayegh MH; Sykes M
    Nat Med; 2000 Apr; 6(4):464-9. PubMed ID: 10742157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.